Answers are grounded in this paper and cite their sources.
The findings from this study require further validation in pre- and posttreated bipolar and schizophrenia subjects, but suggest that the pharmacometabolome may be diagnosis specific.
No takes yet. Share an insight, caveat, or question.
Burghardt et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: